Thus, although limited publications show relationships between the variant and pancreatic cancer, PreMedKB greatly helped us recognize the variation in SPINK1 as the genomic risk factor of this 49-year-old pancreatic cancer patient. This evidence concerns the gene SPINK1 and pancreatic neoplasm.